What's happening in the industry

EU Council unanimously adopts medical device and in vitro diagnostics regulations read on...

Foundation Medicine, Bristol-Myers Squibb collaborate on tumor profiling read on...

Merck's Keytruda gets FDA nod for lymphoma indication read on...

FDA will allow 23andMe to sell genetic tests for disease risk to consumers read on...

Online decision platform that helps oncologists and patients choose personalized medicine read on...

NICE rejects Opdivo in head and neck cancer before it gains marketing approval read on...

Quest Diagnostics and LabCorp sued for excessive charges read on...

CMS announces 60-day extension of PAMA clinical lab reporting deadline read on...

OncoCyte applies for CLIA Lab Certification read on...

Foundation Medicine mining clinical sequencing data for new determinants of immunotherapy response read on...

NGS error correction method described at AACR as excitement grows for early cancer detection read on...

Metastatic melanoma study highlights genetics of checkpoint blockade response read on...

Roche's much-anticipated MS game-changer, Ocrevus, nabs its FDA green light read on...

Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio read on...

FDA grants Osimertinib full approval for EGFR T790M-positive NSCLC read on...

Emma Walmsley appointed GSK CEO read on...

TESARO announces FDA approval of ZEJULA™ (Niraparib) for recurrent ovarian cancer read on...

Blue Earth gets EMA nod for prostate cancer imaging agent read on...

AbbVie granted priority review in Japan for its investigational regimen of Glecaprevir/Pibrentasvir for the treatment of all major genotypes of chronic Hepatitis C read on...

HTG Molecular gets CE mark for lung cancer diagnostic test read on...

Biocartis receives grant for development of a fully automated MSI test read on...

NeoGenomics and Definiens enter into agreement to develop novel assays for clinical trials and clinical testing read on...

MDxHealth signs agreement with Lab21 to make SelectMDx liquid biopsy test available in the UK read on...

Myriad Genetics launches the EndoPredict® test in the US for patients with breast cancer read on...

Roche Diagnostics recognizes Poplar Healthcare as Roche Molecular Center of Excellence read on...

With Brexit underway, EU drug agency prepares to leave London read on...

eFFECTOR Therapeutics to collaborate with CGI read on...

Loxo Oncology announces Larotrectinib Pan-TRK IHC companion diagnostic collaboration with Ventana read on...

Myriad Genetics and BeiGene sign agreement to develop companion diagnostics for use with BeiGene's novel PARP inhibitor, BGB-290 read on...

FDA accepts for priority review BMS application for Opdivo (nivolumab) in previously treated dMMR or MSI-H metastatic colorectal cancer read on...

HISTALIM strengthens its positioning in multiplex IHC and companion diagnostic by integrating two new Roche diagnostics platforms read on...

Helomics® Corporation and SCOPE International USA, Inc. announce the completion of a strategic agreement to co-market products and services read on...

Carbon Health gets $6.5m to begin rollout of digital platform to integrate multiple parts of healthcare read on...

The Screen Project launches BRCA screening across Canada read on...

Sanofi Genzyme extends its Multiple Myeloma Journey Partners Program to cities nationwide to help improve patient outcomes through peer-to-peer education read on...

Novartis expands development programs for NASH through clinical collaboration with Allergan read on...

Precision medicine is our best hope in the fight against cancer read on...

What you might have missed

Diaceutics signs multi-million-euro partnership with BioReference Laboratories to improve patient outcomes
Diaceutics announces 30 jobs on back of 60% revenue growth
Pharma Readiness for Diagnostic Integration 2017
Pharma Readiness for Diagnostic Integration 2017